Compression therapy reimbursement — the Medicare, Medicaid, and private insurance coverage policies that determine patient access to compression products — creates the commercial market access framework, with the Compression Therapy Market reflecting reimbursement as the most commercially significant market access determinant.

Medicare compression coverage evolution — historically limited to surgical anti-embolism stockings for hospital patients and pneumatic compression devices for specific diagnoses (lymphedema post-LTA, venous insufficiency with specific criteria) — has created inconsistent access. The Lymphedema Treatment Act (2022) creating the first Medicare benefit for lymphedema compression supplies represents the most significant reimbursement policy change in compression therapy history.

Private insurance compression coverage — highly variable across health plans with some covering medically indicated compression for chronic venous insufficiency and lymphedema while others limiting coverage to DVT prevention and surgical settings — creates the payer landscape complexity that compression therapy providers navigate. Preauthorization requirements for custom compression garments and documented clinical justification requirements creating administrative burden.

German statutory health insurance (GKV) reimbursement model — providing comprehensive compression stocking coverage for all chronic venous insufficiency patients — represents the international gold standard for compression therapy access that demonstrates how comprehensive coverage drives market scale. Germany's systematic reimbursement creating the world's highest per-capita compression stocking utilization rate as the commercial outcome of adequate coverage.

Do you think the US should move toward comprehensive insurance coverage for medical compression products similar to German statutory insurance, given the evidence that compression therapy reduces costly complications like venous leg ulcers?

FAQ

What compression therapy products does Medicare cover? Medicare covers: pneumatic compression devices (lymphedema, venous insufficiency with specific criteria); compression bandages post-Lymphedema Treatment Act (2022) for lymphedema; surgical anti-embolism stockings for hospital patients; standard compression stockings historically NOT covered except with specific diagnoses; LTA significantly expanding coverage.

How does German compression therapy coverage differ from the US? German GKV covers compression stockings for all clinically indicated chronic venous insufficiency; prescription required; fitting by certified orthotist; no significant cost-sharing; creates highest per-capita compression utilization globally; demonstrates market-expanding effect of comprehensive coverage.

#CompressionTherapy #CompressionReimbursement #MedicareCompression #LymphedemaTreatmentAct #CompressionCoverage #InsuranceCompression